<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04768283</url>
  </required_header>
  <id_info>
    <org_study_id>2019-12-19 BE-2-107</org_study_id>
    <nct_id>NCT04768283</nct_id>
  </id_info>
  <brief_title>Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome</brief_title>
  <official_title>Evaluation of Cardiac Rehabilitation Functional and Physical Capacity, Health-related Quality of Life and Associations With Frailty in Older Patients After Ischemic Heart Disease and Interventional Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lithuanian University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lithuanian University of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate functional and physical capacity, health-related quality&#xD;
      of life and associations with frailty in older patients after ischemic heart disease and&#xD;
      interventional treatment with an individualized physical training program in the second phase&#xD;
      of cardiac rehabilitation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frailty level by Edmonton frail scale score</measure>
    <time_frame>baseline</time_frame>
    <description>Frailty measured by The Edmonton frail scale score - 0-3 - fit, 4-5 - vulnerable, 6-7 - mild frailty, 8-9 - moderate frailty,10-17 - severe frailty.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline functional capacity by six minutes walking test (6MWT)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>6MWT measured by meters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline cardiopulmonary exercise capacity by maximal load (maxWatt)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Maximal load measured with spiroergometry by maximal watts</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline quality of life by MacNew questionnaire</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>The MacNew Heart Disease HRQL questionnaire consists of 27 items which fall into three domains (a 13-item physical limitations domain scale, a 14-item emotional function domain scale, and a 13-item social function domain scale). There are 5 items that inquire about symptoms: angina/chest pain, shortness of breath, fatigue, dizziness, and aching legs. The time frame for the MacNew is the previous two weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline physical performance by Short Physical Performance Battery (SPPB)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline muscular strength by one repetition maximum test (1RM)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>1RM test for leg extension measured by kilograms</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Frailty Syndrome</condition>
  <condition>Ischaemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cardiac rehabilitation physical training program included: respiratory muscle training (7 days/week, for 15 minutes) and aerobic exercises on cycle ergometers (6 days/week, for 10-30 minutes, 30-50% watts or 30-50% HRmax).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combinated physical training program:&#xD;
Respiratory exercises, aerobic training will be the same as in the control group.&#xD;
Additional exercises: balance training and strength exercises with weights, elastic resistance rubbers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combinated physical training program:&#xD;
Respiratory exercises, aerobic training will be the same as in the control group.&#xD;
Additional exercises: balance training with static and dynamic balance training device Biodex Balance System TM SD and strength exercises with HUR strength training machines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Additional balance and resistance training - 1</intervention_name>
    <description>Additional exercise program with balance and resistance training three times per week.&#xD;
The balance training included exercises to improve static as well as dynamic balance ability, for 15-20 minutes.&#xD;
The resistance training included exercises with weights (0,5, 1 or 2 kg), elastic resistance rubbers, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets.</description>
    <arm_group_label>Intervention group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Additional balance and resistance training - 2</intervention_name>
    <description>Additional exercise program with balance and resistance training three times per week.&#xD;
The balance training included exercises with static and dynamic balance training device Biodex Balance System TM SD, for 15-20 minutes. Exercises are performed with the following programs: Postural stability training, Limits of stability training, Weight shift training, Maze control training, Random control training, Percent weight-bearing training.&#xD;
The resistance training included exercises with HUR strength training machines, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets. Strength training was performed with the following exercises: Leg press, leg extension, leg abduction, leg adduction.</description>
    <arm_group_label>Intervention group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients after acute coronary syndrome and percutaneous coronary intervention or&#xD;
             coronary bypass surgery;&#xD;
&#xD;
          -  Age 65 years and older;&#xD;
&#xD;
          -  6-minute walk distance (6-MWD) ≥150 meters;&#xD;
&#xD;
          -  Left ventricular ejection fraction ≥ 40%;&#xD;
&#xD;
          -  Patient's agreement to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  combined coronary artery bypass grafting and valve surgery;&#xD;
&#xD;
          -  Cardiac devices;&#xD;
&#xD;
          -  Diseases in the musculoskeletal system or other organs complicating physical activity&#xD;
             and exercise training;&#xD;
&#xD;
          -  Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that&#xD;
             would exclude individuals from participating in cardiac rehabilitation according to&#xD;
             study protocol), cognitive or linguistic deficits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurelija Beigienė, MD</last_name>
    <phone>+37065875579</phone>
    <email>aurelija.beigiene@kaunoklinikos.lt</email>
  </overall_contact>
  <location>
    <facility>
      <name>LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva</name>
      <address>
        <city>Kulautuva</city>
        <state>Kaunas</state>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurelija Beigienė, MD</last_name>
      <phone>+37065875579</phone>
      <email>aurelija.beigiene@lsmuni.lt</email>
    </contact>
    <investigator>
      <last_name>Daiva Petruševičienė, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 21, 2021</study_first_submitted>
  <study_first_submitted_qc>February 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2021</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lithuanian University of Health Sciences</investigator_affiliation>
    <investigator_full_name>Aurelija Beigienė</investigator_full_name>
    <investigator_title>Aurelija Beigienė, MD</investigator_title>
  </responsible_party>
  <keyword>Frailty</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Cardiac rehabilitation</keyword>
  <keyword>Exercise training</keyword>
  <keyword>Resistance training</keyword>
  <keyword>Balance training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

